Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma

Blood (2017) 130 (Supplement 1): 2730.

https://doi.org/10.1182/blood.V130.Suppl_1.2730.2730

Published: 2017

Journal Articles

Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated-Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams -075

Blood (2015) 126 (23): 3920.

https://doi.org/10.1182/blood.V126.23.3920.3920

Published: 2015

Journal Articles

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

Fabrice Jardin, MD PhD, Anais Pujals, PhD, Laura Pelletier, PhD, Elodie Bohers, PhD, Vincent Camus, Sylvain Mareschal, Sydney Dubois, Marlène Ochman, MD, Francois Lemonnier, MD, Pierre-Julien Viailly, Philippe Bertrand, PhD, Catherine Maingonnat, Alexandra Traverse-Glehen, Philippe Gaulard, MD PhD, Diane Damotte, MD PhD, Richard Delarue, MD, Corinne Haioun, MD PhD, Yosef Landesman, PhD, William Senapedis, PhD, Christian Argueta, PhD, Gilles Andre Salles, MD PhD, Jean-Philippe Jais, MD PhD, Martin Figeac, PhD, Christiane Copie-Bergman, MD PhD, Thierry Molina, Jean-Michel Picquenot, PhD, Marie Cornic, Thierry Fest, MD PhD, Noel Milpied, Emilie Lemasle, MD, Aspasia Stamatoullas, MD, Peter Moeller, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Christer Sundstrom, MD PhD, Christian Bastard, MD PhD, Hervé Tilly, MD PhD, Karen Leroy, MD PhD

Blood (2015) 126 (23): 129.

https://doi.org/10.1182/blood.V126.23.129.129

Published: 2015

Journal Articles

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Imane Azzaoui, PhD, Fabrice Uhel, MD, Delphine Rossille, PhD, Céline Pangault, PharmD PhD, Joelle Dulong, Jerome Le Priol, PhD, Thierry Lamy, MDPhD, Roch Houot, MD PhD, Steven Le Gouill, MD PhD, Guillaume Cartron, MD PhD, Pascal Godmer, MD, Krimo Bouabdallah, MD, Noel Milpied, MD PhD, Karin Tarte, PhD, Thierry Fest, MD PhD, Mikael Roussel, MD PhD

Blood (2015) 126 (23): 1478.

https://doi.org/10.1182/blood.V126.23.1478.1478

Published: 2015

Journal Articles

Characterization of the DNA Methylome during Human B-Cell Differentiation

Blood (2014) 124 (21): 4346.

https://doi.org/10.1182/blood.V124.21.4346.4346

Published: 2014

Journal Articles

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Thierry Fest, MD PhD, James R Cerhan, MD PhD, Maher K Gandhi, PhD FRACP, FRCPath, FRCP, Imane Azzaoui, PhD, Pauline Crooks, BSc, Matthew J Maurer, MS, Noel Milpied, MD PhD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, Thierry Lamy, MD PhD, Stephen M. Ansell, MD PhD, Susan L Slager, PhD, Andrew L. Feldman, MD, Mikael Roussel, MD PhD, Thomas M Habermann, MD, Herve Ghesquieres, MD PhD, Thomas E. Witzig, MD, Brian K Link, MD, Delphine Rossille, PhD

Blood (2014) 124 (21): 2998.

https://doi.org/10.1182/blood.V124.21.2998.2998

Published: 2014

Journal Articles

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Daniel Olive, MD, PhD, Kieu Suong Le, Mikael Roussel, MD PhD, Florence Broussais, MD, Imane Azzaoui, PhD, Delphine Rossille, Reda Bouabdallah, MD, Thierry Fest, MD PhD, Luc Xerri, Thierry Lamy, MD PhD, Céline Pangault, PharmD, PhD

Blood (2014) 124 (21): 1665.

https://doi.org/10.1182/blood.V124.21.1665.1665

Published: 2014

Journal Articles

Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient’s Overall Survival

Thierry Fest, MD, PhD, Delphine Rossille, PhD, Mélanie Gressier, Pharma.D., MSc, Delphine Maucort-Boulch, MD, PhD, Diane Damotte, MD PhD, Céline Pangault, PharmD, PhD, Steven Le Gouill, MD, PhD, Karin Tarte, PharmD, PhD, Thierry Lamy, MD, PhD, Noel Milpied, MD

Blood (2013) 122 (21): 361.

https://doi.org/10.1182/blood.V122.21.361.361

Published: 2013

Journal Articles

A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study

Blood (2013) 122 (21): 76.

https://doi.org/10.1182/blood.V122.21.76.76

Published: 2013

Journal Articles

Whole Blood Transcriptional Profiling of DLBCL At Diagnosis: Evidence of Systemic Changes Altering T-Cell Signaling Pathways

Delphine Rossille, PhD, Céline Pangault, PharmD, PhD, Xavier Cahu, MD, Thierry Lamy, MD, PhD, Burgun Anita, MD, PhD, Noel Milpied, MD, Thierry Fest, MD, PhD

Blood (2011) 118 (21): 2435.

https://doi.org/10.1182/blood.V118.21.2435.2435

Published: 2011

Journal Articles

Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia - A GRAALL Study

Blood (2011) 118 (21): 572.

https://doi.org/10.1182/blood.V118.21.572.572

Published: 2011

Journal Articles

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Karin Tarte, PhD, Pangault Celine, PhD, Patricia Ame-Thomas, PhD, Philippe Ruminy, PhD, Delphine Rossille, Gersende Caron, PhD, Maryse Bahia, John De Vos, MD, PhD, Mikael Roussel, MD, PhD, Celine Monvoisin, Thierry Lamy, MD, PhD, Philippe Gaulard, MD, Herve Tilly, MD, Thierry Fest, MD, PhD

Blood (2009) 114 (22): 757.

https://doi.org/10.1182/blood.V114.22.757.757

Published: 2009

Journal Articles

Post-Induction Minimal Residual Disease (MRD) Defines a Large Subset of Adults with Favorable Ph-Negative Acute Lymphoblastic Leukemia (ALL), Who Do Not Benefit From Allogeneic Stem Cell Transplantation (SCT) in First Complete Remission: A GRAALL Study.

Blood (2009) 114 (22): 577.

https://doi.org/10.1182/blood.V114.22.577.577

Published: 2009

Journal Articles

Quantitative and Functional Alterations of the Gamma Delta T-Cell Subset within Follicular Lymphoma Microenvironment.

Sophie de Guibert, MD, Jean-Baptiste Thibert, Céline Bonnaventure, Patricia Ame-Thomas, PhD, Céline Pangault, PhD, Thierry Fest, MD, PhD, Thierry Lamy, MD, PhD, Karin Tarte, PhD

Blood (2007) 110 (11): 2601.

https://doi.org/10.1182/blood.V110.11.2601.2601

Published: 2007

Journal Articles

WBC Differential by Flow Cytometry: The First Routine Application in a Large University Hospital Clinical Laboratory.

Mikael Roussel, MD, Cyrille Benard, MT, Béatrice Ly Sunnaram, Danielle Gerard, MT, Jean Feuillard, MD, PhD, Thierry Fest, MD, PhD

Blood (2007) 110 (11): 3845.

https://doi.org/10.1182/blood.V110.11.3845.3845

Published: 2007

Journal Articles

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Karin Tarte, PhD, Céline Pangault, PhD, John de Vos, MD, PhD, Philippe Ruminy, PhD, Fabienne Sauvee, Patrick Tas, MD, Jean-Michel Picquenot, MD, Hervé Tilly, MD, PhD, Thierry Lamy, MD, PhD, Christian Bastard, MD, PhD, Thierry Fest, MD, PhD

Blood (2007) 110 (11): 355.

https://doi.org/10.1182/blood.V110.11.355.355

Published: 2007

Journal Articles

Influence of Inflammatory Factors Produced during Graft-Versus-Host Disease on Immunological Properties of Mesenchymal Stem Cells (MSC).

Karin Tarte, PhD, Delphine Monnier, MD, Olivier Tribut, PhD, Joelle Dulong, Céline Bonnaventure, Patricia Ame-Thomas, PhD, Nadège Bescher, Thierry Fest, MD, PhD, Thierry Lamy, MD, PhD, Gilbert Semana, MD, PhD

Blood (2006) 108 (11): 3241.

https://doi.org/10.1182/blood.V108.11.3241.3241

Published: 2006

Journal Articles

Human Mesenchymal Stem Cells Isolated from Bone Marrow and Lymphoid Organs Support Tumor B-Cell Growth: Implications in Follicular Lymphoma Pathogenesis.

Karin Tarte, PhD, Patricia Ame-Thomas, PhD, Hélène Maby-El Hajjami, Céline Monvoisin, Rachel Jean, Thierry Lamy, MD, PhD, Thierry Fest, MD, PhD

Blood (2006) 108 (11): 2409.

https://doi.org/10.1182/blood.V108.11.2409.2409

Published: 2006

Journal Articles

Human Mesenchymal Stem Cells as Precursors of Functional Fibroblastic Reticular Cells: Implications for the Physiopathology of Secondary Lymphoid Organs.

Karin Tarte, PhD, Patricia Ame-Thomas, PhD, Hélène Maby, Sylvie Caulet-Maugendre, MD, PhD, Rachel Jean, Céline Monvoisin, Thierry Lamy, MD, PhD, Thierry Fest, MD, PhD

Blood (2005) 106 (11): 2310.

https://doi.org/10.1182/blood.V106.11.2310.2310

Published: 2005

NARROW

Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Characterization of the DNA Methylome during Human B-Cell Differentiation

Validation of Elevated Blood Soluble PD-L1 As an Independent Prognostic Marker in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient’s Overall Survival

A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study

Whole Blood Transcriptional Profiling of DLBCL At Diagnosis: Evidence of Systemic Changes Altering T-Cell Signaling Pathways

Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia - A GRAALL Study

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Post-Induction Minimal Residual Disease (MRD) Defines a Large Subset of Adults with Favorable Ph-Negative Acute Lymphoblastic Leukemia (ALL), Who Do Not Benefit From Allogeneic Stem Cell Transplantation (SCT) in First Complete Remission: A GRAALL Study.

Quantitative and Functional Alterations of the Gamma Delta T-Cell Subset within Follicular Lymphoma Microenvironment.

WBC Differential by Flow Cytometry: The First Routine Application in a Large University Hospital Clinical Laboratory.

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Influence of Inflammatory Factors Produced during Graft-Versus-Host Disease on Immunological Properties of Mesenchymal Stem Cells (MSC).

Human Mesenchymal Stem Cells Isolated from Bone Marrow and Lymphoid Organs Support Tumor B-Cell Growth: Implications in Follicular Lymphoma Pathogenesis.

Human Mesenchymal Stem Cells as Precursors of Functional Fibroblastic Reticular Cells: Implications for the Physiopathology of Secondary Lymphoid Organs.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only